Biomatics Capital
  • Portfolio
  • News
  • Contact
  • Investor Portal
Select Page

Denali Therapeutics Reports Full Year 2018 Financial Results and Business Highlights

by bizlift | Mar 12, 2019 | Denali Press Releases, Portfolio News

GreatPoint Ventures Invest in Leading Gene Therapy Delivery Platform

by bizlift | Mar 1, 2019 | GuideRX Press Releases, Portfolio News

GreatPoint Ventures Invests In Leading Gene Therapy Delivery Platform

by bizlift | Mar 1, 2019 | GuideRX Press Releases, Portfolio News

Editas Medicine Announces Fourth Quarter and Full Year 2018 Results and Update

by bizlift | Feb 28, 2019 | Editas Press Releases, Portfolio News

Editas Medicine Supports Global Movement to Raise Awareness on Rare Disease Day®

by bizlift | Feb 28, 2019 | Editas Press Releases, Portfolio News

Denali Therapeutics Announces First Patient Dosed in Phase 1B Study of DNL747 for Alzheimer’s Disease

by bizlift | Feb 15, 2019 | Denali Press Releases, Portfolio News

« Older Entries
Next Entries »
© Copyright 2026 Biomatics Capital